Hepatoprotective Effect of Kaempferol—A Review
Open Access
Abstract
Liver diseases, including chronic inflammation and related metabolic dysfunction-associated steatotic liver disease (MASLD), fibrosis and cirrhosis remain a growing global health burden. Currently, available pharmacotherapy for liver dysfunction has limited efficacy. Kaempferol, a naturally occurring flavonoid, has demonstrated significant hepatoprotective effects in preclinical models. This substance activates the SIRT1/AMPK signalling pathway, improves mitochondrial function, inhibits proinflammatory cytokine production via TLR4/NF-κB suppression and attenuates hepatic stellate cell activation by modulating the TGF-β/Smad pathway. In addition, kaempferol regulates the composition of the gut microbiota, thus improving bile acid metabolism and alleviating steatosis and fibrosis. This review presents an integrated analysis of recent in vitro and in vivo studies on the mode of action and utility of kaempferol in liver disease and hepatoprotection.Keywords
This publication has 126 references indexed in Scilit:
- Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosisPhytotherapy Research, 2024
- A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: Role of NF‐κB inhibition and Nrf2 activationBioFactors, 2022
- Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate CellsHepatology, 2020
- Therapeutic effects of kaempferol affecting autophagy and endoplasmic reticulum stressPhytotherapy Research, 2019
- A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: Evidence from preclinical studiesPhytotherapy Research, 2019
- Chemo‐preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive reviewPhytotherapy Research, 2018
- The mechanism of kaempferol induced apoptosis and inhibited proliferation in human cervical cancer SiHa cell: From macro to nanoScanning, 2016
- Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in ratsBiopharmaceutics & Drug Disposition, 2009
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Mutagenicity of kaempferol in V79 cells: The role of cytochromes P450Teratogenesis, Carcinogenesis, and Mutagenesis, 1996